Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI) had Debt to Equity Ratio of 0.02 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.49M |
|
$3.58M |
|
$1.61M |
|
$-1.12M |
|
$2.96M |
|
$-2.47M |
|
$6.04M |
|
$3.58M |
|
$3.58M |
|
$3.58M |
|
$3.58M |
|
$3.58M |
|
$3.58M |
|
$-2.47M |
|
$-2.01M |
|
3.79M |
|
3.79M |
|
$0.94 |
|
$0.94 |
|
| Balance Sheet Financials | |
$3.61M |
|
$10.99M |
|
$13.97M |
|
$17.59M |
|
$2.69M |
|
$0.29M |
|
$3.14M |
|
$5.83M |
|
$6.13M |
|
$11.76M |
|
$11.76M |
|
3.54M |
|
| Cash Flow Statement Financials | |
$-1.46M |
|
$2.75M |
|
$0.01M |
|
$1.81M |
|
$3.11M |
|
$1.30M |
|
$0.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.35 |
|
-- |
|
-- |
|
0.02 |
|
|
Debt to Equity Ratio |
0.02 |
-228.63% |
|
-504.50% |
|
-504.50% |
|
-- |
|
731.49% |
|
731.49% |
|
$-1.46M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
0.98 |
|
92.02 |
|
58.31% |
|
30.41% |
|
20.34% |
|
29.69% |
|
$3.33 |
|
$-0.39 |
|
$-0.38 |
|